EA201990451A1 - Композиция многовалентных пневмококковых конъюгатов капсульного полисахарида с белком-носителем и ее применение - Google Patents
Композиция многовалентных пневмококковых конъюгатов капсульного полисахарида с белком-носителем и ее применениеInfo
- Publication number
- EA201990451A1 EA201990451A1 EA201990451A EA201990451A EA201990451A1 EA 201990451 A1 EA201990451 A1 EA 201990451A1 EA 201990451 A EA201990451 A EA 201990451A EA 201990451 A EA201990451 A EA 201990451A EA 201990451 A1 EA201990451 A1 EA 201990451A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- composition
- protein
- pneumo
- valent
- cock
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000002775 capsule Substances 0.000 title abstract 2
- 229920001282 polysaccharide Polymers 0.000 title abstract 2
- 239000005017 polysaccharide Substances 0.000 title abstract 2
- -1 POLYSACCHARIDE COMPOUNDS Chemical class 0.000 title 1
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 208000035109 Pneumococcal Infections Diseases 0.000 abstract 1
- 241000193998 Streptococcus pneumoniae Species 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
Изобретение относится к вакцинной композиции для предупреждения пневмококковых заболеваний и к иммуногенной композиции против Streptococcus pneumoniae, которая содержит 13 или 14 типов конъюгатов капсульного полисахарида с белком-носителем.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20160114591 | 2016-09-06 | ||
PCT/KR2017/009569 WO2018048141A1 (ko) | 2016-09-06 | 2017-08-31 | 다가 협막 다당류-운반 단백질을 포함하는 조성물 및 이의 용도 |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201990451A1 true EA201990451A1 (ru) | 2019-08-30 |
Family
ID=61561397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201990451A EA201990451A1 (ru) | 2016-09-06 | 2017-08-31 | Композиция многовалентных пневмококковых конъюгатов капсульного полисахарида с белком-носителем и ее применение |
Country Status (12)
Country | Link |
---|---|
KR (1) | KR101991457B1 (ru) |
BR (1) | BR112019004303A2 (ru) |
EA (1) | EA201990451A1 (ru) |
JO (1) | JOP20190038B1 (ru) |
MA (1) | MA45283B1 (ru) |
MX (1) | MX2019002552A (ru) |
MY (1) | MY192792A (ru) |
PH (1) | PH12019500377A1 (ru) |
SA (1) | SA519401232B1 (ru) |
TN (1) | TN2019000064A1 (ru) |
WO (1) | WO2018048141A1 (ru) |
ZA (1) | ZA201901969B (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019139692A2 (en) | 2017-12-06 | 2019-07-18 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
CA3089007A1 (en) | 2018-02-05 | 2019-08-08 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
AU2019256218A1 (en) | 2018-04-18 | 2020-12-03 | Sk Bioscience Co., Ltd. | Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof |
MX2021007496A (es) | 2018-12-19 | 2021-08-05 | Merck Sharp & Dohme Llc | Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y sus metodos de uso. |
WO2023218322A1 (en) * | 2022-05-11 | 2023-11-16 | Pfizer Inc. | Process for producing of vaccine formulations with preservatives |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3828145B2 (ja) * | 1993-09-22 | 2006-10-04 | ヘンリー エム.ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン | 免疫原性構成物の製造のための新規シアン化試薬を使った可溶性炭水化物の活性化方法 |
EP2425854A1 (en) * | 2005-04-08 | 2012-03-07 | Wyeth LLC | Multivalent pneumococcal polysaccharide-protein conjugate composition |
CN107080838A (zh) * | 2010-06-04 | 2017-08-22 | 惠氏有限责任公司 | 疫苗制剂 |
KR102057217B1 (ko) * | 2012-06-20 | 2020-01-22 | 에스케이바이오사이언스 주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
CN103893751B (zh) * | 2014-03-26 | 2016-04-20 | 天津康希诺生物技术有限公司 | 一种肺炎球菌多糖蛋白缀合疫苗及其制备方法 |
CN104069504B (zh) * | 2014-05-11 | 2019-09-24 | 江苏康泰生物医学技术有限公司 | 一种增强多糖蛋白结合物免疫原性的方法 |
-
2017
- 2017-08-31 WO PCT/KR2017/009569 patent/WO2018048141A1/ko active Application Filing
- 2017-08-31 MA MA45283A patent/MA45283B1/fr unknown
- 2017-08-31 KR KR1020170111180A patent/KR101991457B1/ko active IP Right Grant
- 2017-08-31 MY MYPI2019001207A patent/MY192792A/en unknown
- 2017-08-31 JO JOP/2019/0038A patent/JOP20190038B1/ar active
- 2017-08-31 BR BR112019004303A patent/BR112019004303A2/pt unknown
- 2017-08-31 EA EA201990451A patent/EA201990451A1/ru unknown
- 2017-08-31 TN TNP/2019/000064A patent/TN2019000064A1/en unknown
- 2017-08-31 MX MX2019002552A patent/MX2019002552A/es unknown
-
2019
- 2019-02-21 PH PH12019500377A patent/PH12019500377A1/en unknown
- 2019-03-04 SA SA519401232A patent/SA519401232B1/ar unknown
- 2019-03-29 ZA ZA2019/01969A patent/ZA201901969B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JOP20190038A1 (ar) | 2019-03-06 |
KR20180027353A (ko) | 2018-03-14 |
PH12019500377A1 (en) | 2019-10-21 |
MY192792A (en) | 2022-09-09 |
JOP20190038B1 (ar) | 2023-09-17 |
MA45283B1 (fr) | 2021-05-31 |
MX2019002552A (es) | 2019-07-01 |
WO2018048141A1 (ko) | 2018-03-15 |
MA45283A1 (fr) | 2019-06-28 |
SA519401232B1 (ar) | 2022-10-23 |
ZA201901969B (en) | 2019-12-18 |
TN2019000064A1 (en) | 2020-07-15 |
BR112019004303A2 (pt) | 2019-05-28 |
KR101991457B1 (ko) | 2019-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201990451A1 (ru) | Композиция многовалентных пневмококковых конъюгатов капсульного полисахарида с белком-носителем и ее применение | |
BR112016015835A2 (pt) | Polissacarídeos capsulares de streptococcus pneumoniae e conjugados destes | |
PH12021550318A1 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
BR112016016580A2 (pt) | Polissacarídeos capsulares de streptococcus pneumoniae e conjugados dos mesmos | |
WO2015164392A8 (en) | Novel anti-rnf43 antibodies and methods of use | |
WO2015143123A3 (en) | Antibodies against immunogenic glycopeptides, composition comprising the same and use thereof | |
MX2019004690A (es) | Constructos de anticuerpos. | |
MX2016003621A (es) | Vacunas sinteticas libres de proteina y peptido contra streptococcus pneumoniae tipo 3. | |
CO2017001087A2 (es) | Anticuerpos anti proteína similar a angiopoyetina 4 | |
BR112017005993A2 (pt) | derivados de peptídeo inovadores e usos dos mesmos | |
EA202091403A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола |